11
November

08:00 AM EST

Bioinformatics and IT

Name: Bioinformatics and IT Strategy Meeting East Coast 2024 (Boston)
Start: 2024-11-11T08:00
End: 2024-11-11T18:00
Location: Crowne Plaza, London Docklands

Strategy Meeting East Coast USA 2024

Staying Updated with the Current Trends in Recent Technological Advancements Due to the Continual Growth in Bioinformatics

Le Meridien Cambridge Boston

Our Event Starts In

–
days

–
hours

–
minutes

–
seconds

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Bioinformatics Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Bioinformatics professionals from across the East Coast, in Boston MA, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our 2024 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Bioinformatics strategy meeting.

Adam Marko

Life Sciences Field CTO Hammerspace

Basma Hashmi

Head, Digital Solutions Takeda

Bertrand Le Bourdonnec

Chief Scientific Officer HDAX Therapeutics

Bin Li

Senior Director, Computational Biology, Computational Research & Data Strategy Takeda

Diane Joseph-McCarthy

Executive Director, Bioengineering Technology & Entrepreneurship Center Boston University

Dr. Chandra Sekhar Pedamallu

Vice President, Bioinformatics Excelra

Chandra Sekhar Pedamallu comes with extensive experience in Bioinformatics and Computational Biology specializing in cancer genomics. Before joining Excelra, Chandra was associated with Sanofi Inc., identifying novel drug targets in Oncology (Molecular and Immuno-oncology). Prior to Sanofi, he was at Dr. Meyerson Lab, Dana-Farber Cancer Institute, and a visiting scientist at The Broad Institute of MIT and Harvard. During his6-year tenure at Harvard, he led microbial analysis, pathogen discovery projects in cancer and other diseases. He has contributed substantially to over a dozen projects under the auspices of the Cancer Genome Atlas (TCGA).
Chandra holds a Ph.D. in Systems Engineering (area of research : Global Optimization) from School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore. He has co-authored over 85 manuscripts, published in highly reputed journals including Nature, Nature Genetics, Science, Cell, PNAS, etc., and has been inducted as a Fellow of the Royal Society of Biology (FRSB).

Govinda Bhisetti

Vice President and Head of Computational Chemistry Cellarity

Guia Guffanti

Executive Director, Bioinformatics Sumitomo Pharma America, Inc.

Hongyue Dai

Vice President, Translational Bioinformatics LifeMine Therapeutics

Hongyue Dai joined Cygnal Therapeutics in 2019. He formerly served as chief scientific officer (CSO) and chief bioinformatics officer (CBIO) at M2Gen, where he helped build the ORIEN, a cancer center network, to connect cancer hospitals with pharma companies for cancer research and drug development. While at M2Gen, Hongyue filed more than 10 patents on cancer prognosis models covering various cancer types.
Hongyue also served as Executive Director of Informatics & Analysis in Discovery & Preclinical Sciences at Merck Research Labs. He managed genomics and genetics projects to support all therapeutic franchises for target identification, biomarker discovery, compound prioritization, and translating biomarkers in clinical trials.
Prior to Merck, Hongyue was Research Associate Professor in the Physics Department at the University of Utah, where he analyzed and defended the highest energy cosmic ray particle, also known as the Oh-My-God or OMG particle. He then took on the role of Senior Data Analyst at Rosetta, where he co-developed the first microarray data error model to characterize the data uncertainty. He made significant contributions to the first FDA-approved multi-gene test kit for breast cancer prognosis, the MammaPrint. He also collaborated with Celera to develop the 14-gene test kit for ER-positive breast cancer patients.
Hongyue received his undergraduate degree in nuclear physics from Peking University and his Ph.D. in astrophysics from the Institute of High Energy Physics of the Chinese Academy of Science.

Kevin Dushney

SVP, IT and Operations Kymera Therapeutics

Jacob Hesterman

Chief Data Officer Ratio Therapeutics

Jeron Chen

Director and Head of Data Science Voyager Therapeutics, Inc.

Lihua Yu

Chief Data Officer FogPharma

As FogPharma’s chief data officer, Lihua Yu is responsible for the development and implementation of data science strategy across all R&D functions and research programs, as well as establishing digital and machine learning platform to power the design-make-test-predict cycle of the company’s proprietary Helicon™ discovery platform. Lihua brings more than 20 years of experience and leadership in data science across computational biology, cancer genomics, research informatics, clinical genomics, real world data and evidence.
Prior to joining FogPharma, Lihua was the president and chief data science officer at H3 Biomedicine and served in multiple roles during her tenure of nearly a decade. She established H3 as a bioinformatics powerhouse studying splicing regulation in cancer, and is recognized with AACR 2020 Team Science Awards for their contribution to Pan-Cancer Atlas. At H3, she held overall responsibilities for the company’s R&D and was responsible for driving the expanded use of data and technology and leading the creation of a data science/cancer genomics/information-sharing engine supporting all phases of drug discovery and early clinical development. Lihua led H3 during its transition from a drug discovery company to an early phase drug development company. Prior to H3, she was the cancer bioinformatics leader at AstraZeneca and held roles of increasing responsibility from 2000 to 2011.
Lihua holds a Ph.D. in biomedical engineering from Boston University working under Dr. Temple Smith, and her M.S. and B.S. in biomedical engineering from Tsinghua University in Beijing, China.

Lorena Pantano

Director, Bioinformatics Platform Harvard T.H. Chan School of Public Health

ML Ujwal

Associate Director, Data Science R&D J&J US

Nathan McBride

Senior Vice President, IT Xilio Therapeutics, Inc.

Raj Bandaru

Global Head, Analytics, Health Economics and Outcomes Research AstraZeneca

Vikas Patel

Former Global Head, R&D Digital and Data Platforms Sanofi

Zev Wisotsky

Director, Drug Discovery New Modality Solutions Revvity Signals

Ziv Bar-Joseph

Vice President, Head, R&D Data and Computational Sciences Sanofi

Ziv Bar-Joseph is Vice President and Head, R&D Data and Computational Sciences at Sanofi and the FORE Systems Professor of Machine Learning Department and Computational Biology in the School of Computer Science at Carnegie Mellon University (CMU). Dr. Bar-Joseph received his PhD in computer science from MIT in 2003. His work is focused on the development of machine learning methods for the processing, analysis, visualization, and modeling of high-throughput biological data. He has recently worked on the analysis and modeling of single-cell data from several modalities and on methods for integrating this data with bulk interaction data to reconstruct networks within and between cells. Dr. Bar-Joseph is involved in a number of national efforts focused on using single cell data to create 3D reference human maps. He led the Computational Tools Center for the NIH HuBMAP program and is a PI in the SenNet Data Coordination Center. He was also the director of the Joint CMU Pitt PhD Program in Computational Biology (CPCB). Dr. Bar-Joseph is the recipient of the Overton prize, the annual award of the Intentional Society for Computational Biology (ISCB), and the NSF CAREER award. He is also the recipient of several best paper awards, including at the top computational biology conferences, Recomb and ISMB.

Robin Ellis

Partner (former Head Patents - IP Product Strategy at Sandoz) Reddie & Grose GmbH Patent & Trade Mark Attorneys

Agenda

See Which Topics Are Discussed at the Strategy Meeting

09:00 - 10:00

Roundtable Tracks

Digital Transformation
Target validation and small molecule hit identification in the era of modern drug discovery

Data Science & Analytics
Tackling How Cloud Computing is a Big Changer in Data Analysis

-Raj Bandaru
Global Head, Analytics, Health Economics and Outcomes Research
AstraZeneca

Artificial Intelligence & Machine Learning
Exploring the Potential and Current limitations of AI in Personalized Medicine and Drug Discovery

-Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center
Boston University

Data Management / Big Data
Statistical and Computational Methods for Analyzing Big Bioinformatics Data

-Bertrand Le Bourdonnec
Chief Scientific Officer
HDAX Therapeutics

Clinical Research & Translational Informatics
Analyzing the Current Application of Artificial Intelligence in Clinical Research (Topic TBC)

-Piero Ricchiuto
Associate Director Bioinformatics, Computational Biology & Biomarker Discovery
Alexion, AstraZeneca Rare Disease Unit

Data Integration / Data Mining
Determining Current Issues in Data Integration and Mining

-Hongyue Dai
Vice President, Translational Bioinformatics
LifeMine Therapeutics

11:10 - 12:10

Roundtable Tracks

Digital Transformation
Digital Transformation in Bioinformatics: From Guessing Games to Data-Driven Decisions

-Zev Wisotsky
Director, Drug Discovery New Modality Solutions
Revvity Signals

REVVITY

Data Science & Analytics
High-Throughput Screening Data Analysis Technologies: Development and Implementation in Industry

Sponsor

Artificial Intelligence & Machine Learning
Investigating the State of Bioinformatics Using Sophisticated Artificial Algorithmic Intelligence

Sponsor

Data Management / Big Data
Unifying Data Access And High Performance Data Platforms

-Adam Marko
Life Sciences Field CTO
Hammerspace

HAMMERSPACE

Clinical Research & Translational Informatics
Translational Bioinformatics: Bridging the Gap Between Bench Research and Bedside Clinical Applications

Sponsor

Data Integration / Data Mining
Harnessing Big Data for Drug Discovery

-Dr. Chandra Sekhar Pedamallu
Vice President, Bioinformatics
Excelra

12:15 - 13:15

Roundtable Tracks

Digital Transformation
Embracing Digital Transformation And A New Era In Science

-Nathan McBride
Senior Vice President, IT
Xilio Therapeutics, Inc.

Data Science & Analytics
Challenges And Techniques For Visualizing Multi Omics Data

-Jeron Chen
Director and Head of Data Science
Voyager Therapeutics, Inc.

Artificial Intelligence & Machine Learning
Current Challenges and Limitations of AI/ML in Bioinformatics Research

-Kevin Dushney
SVP, IT and Operations
Kymera Therapeutics

Data Management / Big Data
Data Curation: Identifying the Importance of Ensuring High- Quality, Reliable Datasets

-Raj Bandaru
Global Head, Analytics, Health Economics and Outcomes Research
AstraZeneca

Clinical Research & Translational Informatics
Using Bioinformatics to Identify and Validate Biomarkers (Topic TBC)

-Lihua Yu
Chief Data Officer
FogPharma

Data Integration / Data Mining
Examining How Data Mining Techniques Can be Used to Build Predictive Models

-Govinda Bhisetti
Vice President and Head of Computational Chemistry
Cellarity

15:10 - 16:10

Roundtable Tracks

Digital Transformation
Road Mapping of Digital Transformation in Biotechnology, Biopharma, and Pharma Industry

-Adrianne Lee
Principal Scientist, Head of Research Data Architecture and Operations
Morphic Therapeutic

Data Science & Analytics
How Does Effective Visualization Aid in the Interpretation and Communication of Complex Biological Data?

-Veena Swaminathan
Head, Portfolio Analytics - Global R&D
Sanofi

Artificial Intelligence & Machine Learning
Leveraging AI Use for Better Collaboration and Innovation

-Basma Hashmi
Head, Digital Solutions
Takeda

Data Management / Big Data
Discussing Emerging Technologies and Innovations in Data Management, such as AI-Driven Data Curation and Blockchain for Data Integrity

-Vikas Patel
Former Global Head, R&D Digital and Data Platforms
Sanofi

Clinical Research & Translational Informatics
Enhancing the Effectiveness and Quality of Translational Research

-Deepak Rajpal
Global Head, Pre-Clinical and Translational Sciences
Takeda

Data Integration / Data Mining
Challenges and Solutions for Ensuring Patient Privacy and Data Security in Integrated Bioinformatics Databases

See the agenda and facilitator line-up. Download the strategy meeting brochure for full details.

DOWNLOAD THE BROCHURE

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There's only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we'll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks - however you choose to make those important connections our Strategy Meetings have the solution

Become an official strategy meeting partner

Whatever you business needs, we can help. Get in touch for partnering opportunities

I'D LIKE TO PARTNER

Press play to hear what your colleagues had to say...

Hotel & Venue

Le Méridien Boston Cambridge

Le Méridien Cambridge-MIT’s elegant guest rooms and suites offer a place of luxurious sanctuary and unmatched comfort. Explore unique programs inspired by the brand’s European heritage. Born in a glamorous era of travel, Le Méridien believes everyone should explore the world in style.

Hotel Details Maps & Direction Parking

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

14 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting East Coast USA 2024

21 May 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting West Coast USA 2024

22 Oct 2024

Drug Discovery Biology & Bioinformatics Strategy Meeting Europe 2024

16 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting East Coast USA 2024

23 May 2024

Clinical Operations and Clinical Trial Supply Chain Strategy Meeting West Coast USA 2024

15 May 2024

Medicinal Chemistry Strategy Meeting East Coast USA 2024

22 May 2024

Medicinal Chemistry Strategy Meeting West Coast USA 2024

23 Oct 2024

Medicinal Chemistry Strategy Meeting Europe 2024

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Boston

Drug Discovery Biology Strategy Meeting East Coast – Boston 2024

Bioinformatics and IT

Strategy Meeting East Coast USA 2024

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge Boston

Fresh Bioinformatics Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Meet Our 2024 Facilitators

Adam Marko

Basma Hashmi

Bertrand Le Bourdonnec

Bin Li

Diane Joseph-McCarthy

Dr. Chandra Sekhar Pedamallu

Govinda Bhisetti

Guia Guffanti

Hongyue Dai

Kevin Dushney

Jacob Hesterman

Jeron Chen

Lihua Yu

Lorena Pantano

ML Ujwal

Nathan McBride

Raj Bandaru

Vikas Patel

Zev Wisotsky

Ziv Bar-Joseph

Robin Ellis

Agenda

See Which Topics Are Discussed at the Strategy Meeting

BREAKFAST & REGISTRATION

OPENING KEYNOTE PRESENTATION

Roundtable

Roundtable Tracks

Networking/1-1 Meetings

Roundtable (Solution)

Roundtable Tracks

REVVITY

Sponsor

Sponsor

HAMMERSPACE

Sponsor

Roundtable (Solution)

Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable (Pharma / Biotech)

Roundtable Tracks

Afternoon Refreshment Break

Panel Discussion

14
May
2024

21
May
2024

22
Oct
2024

16
May
2024

23
May
2024

15
May
2024

22
May
2024

23
Oct
2024

Le Meridien Cambridge Boston